Achillion Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 6 of about 6   

Articles published

ACHN 8.41 0.00 (-0.06%)
price chart
Movers & Shakers
To submit items for Movers & Shakers, please email text and high-resolution photos to news@HartfordBusiness.com. St. Francis Hospital and Medical Center in Hartford has named two new C-level executives.
Drugmakers Jockey for Piece of Future Hepatitis C Combo Pill
Next in line may be Idenix Pharmaceuticals Inc. and Achillion Pharmaceuticals Inc., said Raghuram Selvaraju, an analyst with Morgan Joseph TriArtisan in New York.
Gilead Drops as Hepatitis C Drug From $10.8 Billion Buy Fails to Sustain
Achillion Pharmaceuticals Inc. and Idenix Pharmaceuticals Inc., other developers of medicines for the disease, are probably acquisition targets, Selvaraju said.
Hepatitis C: Drugmakers jockey to create cocktail
Next in line may be Idenix Pharmaceuticals and Achillion Pharmaceuticals, said Raghuram Selvaraju, an analyst with Morgan Joseph TriArtisan.
Upgrades & Downgrades: Stock Up on Costco?
OpenTable (OPEN): The restaurant reservation company is downgraded by both Oppenheimer (Perform from Outperform with a $54 target price) and Credit Suisse (Neutral from Outperform.
Edible Mushrooms in Connecticut
This was the first year we joined CVMS, the Connecticut Valley Mycological Society. Every week, weather conditions permitting, the group goes to a site in Connecticut and searches a designated area for any mushrooms.